z-logo
Premium
Is M65 really better than M30 as a biomarker of hepatic fibrosis?
Author(s) -
Yilmaz Yusuf,
Kurt Ramazan
Publication year - 2012
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.25520
Subject(s) - steatosis , fibrosis , nonalcoholic fatty liver disease , medicine , biomarker , gastroenterology , stage (stratigraphy) , steatohepatitis , liver fibrosis , nonalcoholic steatohepatitis , disease , fatty liver , pathology , biology , paleontology , biochemistry

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom